<DOC>
	<DOCNO>NCT02050997</DOCNO>
	<brief_summary>This exploratory , translational , non-interventional multi-centre clinical study . The aim study identify predictive plasma biomarkers response chemotherapy PDAC .</brief_summary>
	<brief_title>Plasma Biomarkers P-DAC , V1</brief_title>
	<detailed_description>This study involve two cohort group , patient involve PDAC . Cohort A : Target 80 resectable PDAC patient receive standard treatment chemotherapy +/- radiotherapy Cohort B : - Cohort B1 = Target 80 unresectable locally advanced PDAC patient receive standard treatment chemotherapy +/- radiotherapy . - Cohort B2 = Target metastatic PDAC patient receive standard treatment chemotherapy +/- radiotherapy . Control patient : Target 50 , acute pancreatitis admit hospital observation/treatment . Blood sample take following time point : - prior resection , whenever feasible cohort A - prior CT , cohort A B - CT , cohort A B - follow-up , approximately every 3 6 month two year cohort A</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<criteria>Age â‰¥ 18 year age Ability give write informed consent Histologically cytologicallyconfirmed PDAC Patients receive standard treatment CT +/ radiotherapy present : Cohort A : resectable cancer OR Cohort B.1 : unresectable locally advanced cancer OR Cohort B.2 : metastatic cancer Eastern Cooperative Oncology Group ( ECOG ) Performance status 0 2 Presence medical psychiatric condition , , opinion investigator , would potentially pose risk patient participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>